Results 21 to 30 of about 84,091 (291)

Bronchiectasis

open access: yesLa Presse Médicale, 2023
Bronchiectasis is a final common pathway of a wide variety of underlying conditions including infectious, autoimmune, allergic, genetic and inflammatory conditions. Patients experience a chronic disease with variable clinical symptoms and course, but most experience cough, sputum production and recurrent exacerbations.
Miguel Barbosa, James D. Chalmers
openaire   +3 more sources

Bronchoscopy, Imaging, and Concurrent Diseases in Dogs with Bronchiectasis: (2003-2014). [PDF]

open access: yes, 2015
BackgroundBronchiectasis is a permanent and debilitating sequel to chronic or severe airway injury, however, diseases associated with this condition are poorly defined.ObjectiveTo evaluate results of diagnostic tests used to document bronchiectasis and ...
Byrne, BA   +4 more
core   +1 more source

Eradication of Burkholderia cepacia Using Inhaled Aztreonam Lysine in Two Patients with Bronchiectasis

open access: yesCase Reports in Pulmonology, 2014
There are not many articles about the chronic bronchial infection/colonization in patients with underlying lung disease other than cystic fibrosis (CF), especially with non-CF bronchiectasis (NCFBQ). The prevalence of B. cepacia complex is not well known
A. Iglesias   +4 more
doaj   +1 more source

The incidence of bronchiectasis in chronic obstructive pulmonary disease

open access: yesOpen Medicine, 2022
Bronchiectasis is a common comorbidity in chronic obstructive pulmonary disease (COPD). There are limited data regarding the incidence of bronchiectasis in COPD.
Lu Hsueh-Yi, Liao Kuang-Ming
doaj   +1 more source

Outcome and prognostic factors after lung transplantation for bronchiectasis other than cystic fibrosis

open access: yesBMC Pulmonary Medicine, 2021
Background While lung transplant (LTX) can be an effective therapy to provide the survival benefit in selected populations, post-transplant outcome in LTX recipients with bronchiectasis other than cystic fibrosis (CF) has been less studied.
Takashi Hirama   +6 more
doaj   +1 more source

<i>Mycobacterium abscessus</i> Pulmonary Disease in a Myasthenia Gravis Patient: A Case Report. [PDF]

open access: yesRespirol Case Rep
Reports on Mycobacterium abscessus complex (MABC) pulmonary disease and Myasthenia Gravis (MG) are rare; to our knowledge, this is the second case describing successful treatment of MABC pulmonary infection in this population and the first with current guideline‐directed therapy.
Lu D   +5 more
europepmc   +2 more sources

Eosinophilic bronchitis, eosinophilic granuloma, and eosinophilic bronchopneumopathy in 75 dogs (2006-2016). [PDF]

open access: yes, 2019
BackgroundEosinophilic lung disease is a poorly understood inflammatory airway disease that results in substantial morbidity.ObjectiveTo describe clinical findings in dogs with eosinophilic lung disease defined on the basis of radiographic, bronchoscopic,
Dear, Jonathan D   +4 more
core   +1 more source

The Efficacy of Therapeutic Respiratory Muscle Training Interventions in People with Bronchiectasis: A Systematic Review and Meta-Analysis [PDF]

open access: yes, 2020
Background: Respiratory muscle dysfunction is an important health problem with high morbidity and mortality and associated costs in patients with bronchiectasis (BC).
Casuso-Holgado, Maria Jesus   +5 more
core   +3 more sources

Pathogenesis, imaging and clinical characteristics of CF and non-CF bronchiectasis

open access: yesBMC Pulmonary Medicine, 2018
Bronchiectasis is a common feature of severe inherited and acquired pulmonary disease conditions. Among inherited diseases, cystic fibrosis (CF) is the major disorder associated with bronchiectasis, while acquired conditions frequently featuring ...
Jürgen Schäfer   +4 more
doaj   +1 more source

Primary vs. Secondary Antibody Deficiency: Clinical Features and Infection Outcomes of Immunoglobulin Replacement [PDF]

open access: yes, 2014
Secondary antibody deficiency can occur as a result of haematological malignancies or certain medications, but not much is known about the clinical and immunological features of this group of patients as a whole. Here we describe a cohort of 167 patients
AA Bousfiha   +55 more
core   +3 more sources

Home - About - Disclaimer - Privacy